Effects of anesthesia upon18F-FDG uptake in rhesus monkey brains

Annals of Nuclear Medicine

Volumn 19, Issue 5, 2005, Pages 373-377

  Itoh, Takashi ^a   Wakahara, Shunichi ^b   Nakano, Takayuki ^b   Suzuki, Kazutoshi ^b   Kobayashi, Kaoru ^c   Inoue, Osamu ^c  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Brain; Conscious; Ketamine; Pentobarbital; Rhesus monkey

Indexed keywords

FLUORODEOXYGLUCOSE F 18; KETAMINE; PENTOBARBITAL; ANESTHETIC AGENT; CENTRAL DEPRESSANT AGENT; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BRAIN; BRAIN CORTEX; COMPARATIVE STUDY; CONSCIOUSNESS; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BRAIN LEVEL; DRUG UPTAKE; MALE; NONHUMAN; OCCIPITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHESUS MONKEY; ANIMAL; ARTIFACT; DRUG EFFECT; KINETICS; MACACA; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; SCINTISCANNING; TISSUE DISTRIBUTION;

ADJUVANTS, ANESTHESIA; ANESTHESIA; ANESTHETICS, DISSOCIATIVE; ANIMALS; ARTIFACTS; BRAIN; FLUORODEOXYGLUCOSE F18; KETAMINE; KINETICS; MACACA MULATTA; MALE; METABOLIC CLEARANCE RATE; PENTOBARBITAL; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 24644490893     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03027401     Document Type: Article

References (26)

1. Parsey RV, Mann JJ. Applications of positron emission tomography in psychiatry. Semin Nucl Med 2003; 33: 129-135.
2. Segall G. Assessment of myocardial viability by positron emission tomography. Nucl Med Commun 2002; 23: 323-330.
3. Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol 2001; 2: 157-164.
4. Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 2002; 32: 47-59.
5. Herholz K. PET studies in dementia. Ann Nucl Med 2003; 17: 79-89.
6. Cohen RM, Semple WE, Gross M, Nordahl TE, King AC, Pickar D, et al. Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology 1989; 2: 241-254.
7. Duncan GE, Miyamoto S, Leipzig JN, Lieberman JA. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism. J Pharmacol Exp Ther 2000; 293: 8-14.
8. Laurie DJ, Pratt JA. Local cerebral glucose utilization following subacute and chronic diazepam pretreatment: differential tolerance. Brain Res 1989; 504: 101-111.
9. Grasby PM, Sharp T, Allen T, Kelly PA, Grahame-Smith DG. Effects of the 5-HT1A partial agonists gepirone, ipsapirone and buspirone on local cerebral glucose utilization in the conscious rat. Psychopharmacology (Berl) 1992; 106: 97-101.
10. Potkin SG, Buchsbaum MS, Jin Y, Tang C, Telford J, Friedman G, et al. Clozapine effects on glucose metabolic rate in striatum and frontal cortex. J Clin Psychiatry 1994; 55: 63-66.
11. Moresco RM, Tettamanti M, Gobbo C, Del Sole A, Ravasi L, Messa C, et al. Acute effect of 3-(4-acetamido)-butyrrillorazepam (DDS2700) on brain function assessed by PET at rest and during attentive tasks. Nucl Med Commun 2001; 22: 399-404.
12. Frykholm P, Andersson JL, Valtysson J, Silander HC, Hillered L, Perss Olsson Y, et al. A metabolic threshold of irreversible ischemia demonstrated by PET in a middle cerebral artery occlusion-reperfusion primate model. Acta Neurol Scand 2000; 102: 18-26.
13. Le Mestric C, Chavoixs C, Chapon F, Mezenge F, Epelbaum J, Baron JC. Effects of damage to the basal forebrain on brain glucose utilization-a reevaluation using positron emission tomography in baboons with extensive unilateral excitotoxic lesion. J Cereb Blood Flow Metab 1998; 18: 476-490.
14. 11C-raclopride against anesthetics in rhesus monkey brain. J Neurol Transm Gen Sect 1995; 100: 147-151.
15. Otsuka T, Wei L, Bereczki D, Acuff V, Patlak C, Fenstermacher J. Pentobarbital produces dissimilar changes in glucose influx and utilization in brain. Am J Physiol 1991; 261: 265-275.
16. 1 receptor binding in rat brain. Synapse 2004; 54: 207-213.
17. Duncan GE, Miyamoto S, Leipzig JN, Lieberman JA. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine. Brain Res 1999; 843: 171-183.
18. Takechi H, Onoe H, Imamura K, Onoe K, Kakiuchi T, Nishiyama S, et al. Brain activation study by use of positron emission tomography unanesthetized monkeys. Neurosci Lett 1994;182: 279-282.
19. Moresco RM, Todde S, Belloli S, Simonelli P, Panzacchi A, Rigamonti M, et al. In vivo imaging of adenosine A(2A) receptors in rat and primate brain using [(11)C]SCH442416. Eur J Nucl Med Mol Imaging 2004.
20. 18F-FDG in Acute Cerebral Radiation Injury in the Rat. J Nucl Med 2004; 45: 1931-1938.
21. Duncan GE, Leipzig JN, Mailman RB, Lieberman JA. Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation. Brain Res 1998; 812: 65-75.
22. 1 receptor alleles predict PET metabolic correlates of clinical response to clozapine. Mol Psychiatry 2003; 8: 109-113.
23. Anis NA, Berry SC, Burton NR, Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-aspartate. Br J Pharmacol 1983; 79: 565-575.
24. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, et al. Subanesthetic effects of the noncompetitive NMDA antagonist ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994; 51: 199-214.
25. Gregoriou M, Trayer IP, Cornish-Bowden A. Allosteric character of the inhibition of rat-muscle hexokinase by glucose 6-phosphate. Eur J Biochem 1986; 161: 171-176.
26. Huang JB, Kindzelskii AL, Petty HR. Hexokinase translocation during neutrophil activation, chemotaxis, and phagocytosis: disruption by cytochalasin D, dexamethason and indometacin. Cell Immunol 2002; 218: 95-106.